Reagent for detecting an analyte

Details for Australian Patent Application No. 2004298540 (hide)

Owner Precisense A/S

Inventors Norrild, Jens Christian; Laursen, Bo Wegge

Agent Spruson & Ferguson

Pub. Number AU-B-2004298540

PCT Pub. Number WO2005/059037

Priority 0329161.4 16.12.03 GB

Filing date 14 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 23 April 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07C 229/40 (2006.01) Compounds containing amino and carboxyl groups bound to the same carbon skeleton

C07C 309/14 (2006.01) Sulfonic acids

C07D 207/404 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 211/66 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C09B 11/10 (2006.01) Diaryl- or triarylmethane dyes

C09B 11/12 (2006.01) Diaryl- or triarylmethane dyes

G01N 21/64 (2006.01) Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light - Fluorescence

G01N 33/533 (2006.01) Investigating or analysing materials by specific methods not covered by groups - with fluorescent label

G01N 33/542 (2006.01) Investigating or analysing materials by specific methods not covered by groups

G01N 33/58 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving labelled substances

C07D 207/40 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/059037 Priority application(s): WO2005/059037

23 April 2009 Application Accepted

  Published as AU-B-2004298540

20 August 2009 Standard Patent Sealed

22 December 2011 Assignment Registered

  Precisense A/S The patent has been assigned to Medtronic Minimed, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298546-P EF-TU expression units

2004298537-Method and nucleic acids for the improved treatment of breast cell proliferative disorders